Association of Immune Cells, Inflammatory Cytokines, and Lung Cancer: A Mediating Mendelian Randomization Study
Mediators of Inflammation · 2025
DOI: 10.1155/mi/3834641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2025. Verfasst von Lang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Jinhua Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, 438 West Shuangxi Road, …. Hauptthemen laut MEDLINE: Lung Neoplasms, Mendelian Randomization Analysis, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Background
Lung cancer oncogenesis involves interactions between immune cells and inflammatory cytokines. However, their causal relationships and mediating mechanism remain unclear.
Methods
Using a mediating Mendelian randomization (MR) approach, we analyzed genome‐wide association study (GWAS) data for 731 immune‐cellular phenotypes, 41 cytokines, and eight related lung cancer phenotypes.
Results
BAFF-R expression in IgD + CD24 + B cells was positively associated with lung adenocarcinoma (LUAD) risk (odds ratio [OR], 1.0168 [95% confidence interval [CI], 1.0006–1.0332]), mediated by macrophage migration inhibition factor (MIF) with a mediation proportion of 14.2% (95% CI, 0.00007–0.0046). CD39 expression on secreting CD4 Tregs was related to an increased risk of small‐cell lung cancer (SCLC) (OR, 1.0306 [95% CI, 1.0006–1.0616]), mediated by interleukin (IL)‐2 and IL‐6 with mediation proportions of 8.43% (95% CI, 0.00005−0.005) and 5.1% (95% CI, 0.00006–0.003), respectively. CD28 expression on CD39 + CD4 + T cells was positively correlated to lung squamous cell carcinoma (LUSC) risk (OR, 1.0335 [95% CI, 1.009–1.0586]), inversely mediated by IL‐16 (95% CI, −0.01 to −0.0003).
Conclusions
These findings reveal the associations between immune cells, inflammatory cytokines, and lung cancer risk, providing insights into cancer diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Jinhua Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, 438 West Shuangxi Road, Jinhua 321017, China.
- Department of Pneumology, Jinhua Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, 438 West Shuangxi Road, Jinhua 321017, China.
- Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, 950 Donghai Street, Quanzhou 362018, Fujian, China.
ORCID-Profile: Lang Li, Yinuo Tangwu, Lvyuan He, Gaochen Lan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
Zitieren
APA
Li, L., Zhu, Y., Zhao, C., Tangwu, Y., He, L., & Lan, G. (2025). Association of Immune Cells, Inflammatory Cytokines, and Lung Cancer: A Mediating Mendelian Randomization Study. Mediators of Inflammation. https://doi.org/10.1155/mi/3834641
Vancouver
Li L, Zhu Y, Zhao C, Tangwu Y, He L, Lan G. Association of Immune Cells, Inflammatory Cytokines, and Lung Cancer: A Mediating Mendelian Randomization Study. Mediators of Inflammation. 2025. doi:10.1155/mi/3834641
BibTeX
@article{Li2025,
author = {Li, Lang and Zhu, Ying and Zhao, Chenchong and Tangwu, Yinuo and He, Lvyuan and Lan, Gaochen},
title = {Association of Immune Cells, Inflammatory Cytokines, and Lung Cancer: A Mediating Mendelian Randomization Study},
journal = {Mediators of Inflammation},
year = {2025},
doi = {10.1155/mi/3834641}
}
EUVIMED